NCT06380686Recruiting
Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome
Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based
Source: ClinicalTrials.gov · Last updated 13 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Prospective, open, non-interventional, multi-center clinical registry study with the aim to establish a comprehensive research platform reflecting the real-world treatment landscape for recurrent/metastatic head and neck tumor patients.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 120 (estimated)
- First submitted
- 12 Apr 2024
- Start date
- 7 Nov 2024
- Primary completion date
- Nov 2029
- Lead sponsor
- AIO-Studien-gGmbH
- Diseases
- Head and neck cancer
- NCT number
- NCT06380686
What you commit to
- Study type: Observational
- Planned participants: 120
- From 7 Nov 2024 to the primary completion date, Nov 2029
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Age ≥ 18 years
- Able to understand and willing to sign written informed consent
- Histologically or cytologically confirmed squamous cell carcinoma of the head and neck (oral cavity, oropharynx, hypopharynx or larynx)
- Patients not amenable for curative treatment who receive palliative systemic treatment or best supportive care
- Informed consent no later than four weeks after start of first-line palliative systemic treatment. For patients receiving "best supportive care only": no later than six weeks after diagnosis/recurrence or metastatic disease
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitätsklinikum Essen Coordinator of this site? Confirm its status | Essen | Germany | Not yet recruiting |
| Onkologie/Studienzentrum am Raschplatz GbR Coordinator of this site? Confirm its status | Hanover | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.